Karin Jirström
181 – 190 of 351
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
- Contribution to journal › Article
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
- Contribution to journal › Article
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
- Contribution to journal › Article
-
Mark
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Coffee and tea consumption, genotype- based CYP1A2 and NAT2 activity and colorectal cancer risk- Results from the EPIC cohort study
- Contribution to journal › Article
-
Mark
SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
- Contribution to journal › Article
-
Mark
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.
- Contribution to journal › Article
-
Mark
Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival - results from the EPIC cohort study.
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
- Contribution to journal › Article
-
Mark
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
- Contribution to journal › Article
